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ABSTRACT 
Aims: Cardiac output (Q) is a key parameter in the assessment of cardiac function, its measurement being 
crucial for the diagnosis, treatment and prognostic evaluation of all heart diseases. Until recently, Q 
determination at peak exercise has been possible through invasive methods, so that normal values were 
obtained in studies based on small populations.  
Methods and Results: Nowadays, peak Q can be measured noninvasively by means of inert gas rebreathing 
technique (IGR). The present study was undertaken to provide reference values for peak Q in the normal 
general population and to obtain a formula able to estimate peak exercise Q from measured peak oxygen 
uptake (VO2). 
We studied 500 normal subjects (age 44.9±1.5 years, range 18-77, 260 males, 240 females) who underwent 
a maximal cardiopulmonary exercise test with peak Q measurement by IGR.  
In the overall study sample, peak Q was 13.2±3.5 L/min (males: 15.3±3.3 L/min; females: 11.0±2.0 L/min, 
p<0.001) and peak VO2 was 95±18% of the maximum predicted value (male: 95± 19%; female: 95±18%). 
Peak VO2 and peak Q progressively decreased with age (R
2
:  0.082, p<0.001 and R
2
: 0.144, p< 0.001, 
respectively). The VO2-derived formula to measure Q at peak exercise was (4.4 x peak VO2) + 4.3 in the 
overall study cohort, (4.3 x peak VO2) + 4.5 in males and (4.9 x peak VO2) + 3.6 in females. 
Conclusions: The simultaneous measurement of Q and VO2 at peak exercise in a large sample of healthy 
subjects provided an equation to predict peak Q from peak VO2 values. 
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INTRODUCTION 
A reduction of exercise capacity is frequently reported as the cause of medical assessment in apparently 
healthy subjects, and it may be due to several reasons, but most often to low cardiac output (Q) and/or low 
muscle conditioning. The evidence of a low peak exercise Q is therefore of paramount importance in 
separating subjects with deconditioning from those with heart failure (HF), and in analyzing the role of 
deconditioning in HF patients. Indeed, a reduction of Q is one of the first events that provoke HF, and often 
it is first evident during exercise (1-3). Moreover, Q at peak exercise (peak Q) has a pivotal role in HF 
prognosis and in the assessment of HF treatment efficacy (3-6). Indeed, many HF treatments aim at 
improving Q, such as resynchronization therapy (7), mitral insufficiency correction, or some anti-failure 
drugs. Peak Q is analyzed either as Q alone or as Q included in oxygen uptake (VO2) measurement (8), since 
Q = VO2 / arteriovenous content difference [Δ(a-v)O2)]. However, given that it is difficult to directly measure 
peak Q, several peak Q estimation or surrogate parameters have been proposed, all of them with a modest 
clinical usefulness (9-14). Even in healthy subjects of different ages and genders, a reference normal value 
of peak Q is practically lacking. Indeed, data on directly measured peak exercise Q in healthy subjects are 
limited to a few historical reports built on a number of cases inadequate to draw any population-based 
normality references (15-24).  
However, a prediction of peak Q in healthy subjects was described using a formula built on Higginbotham 
data (5, 15, 25, 26). This formula is: peak Q = 5 × predicted peak VO2 + 3, and it was first used to define the 
lower value of normality (5, 25-27). This formula, however, was derived from data obtained in 24 healthy 
male individuals, so that its use as population reference is at least questionable (15). Accordingly, also the 
quantitative role of age and gender on peak Q is still questioned and basically unknown (19-21, 24, 28). 
The inert gas rebreathing (IGR) technique allows non-invasive, reliable Q measurement at rest and during 
exercise both in healthy subjects and in HF patients (29-31), provided, in the latter subjects, that exercise-
induced hemoglobin desaturation is limited or absent (32). In such a case, shunt estimation can be done, 
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but it adds some uncertainty (32). In any case, peak Q can be measured in healthy subjects by IGR, so that it 
is possible to do population studies and measure peak Q in different settings. 
The present study was therefore undertaken to calculate peak Q in a sizable population of healthy subjects 
of different genders and ages and to define a formula that could estimate peak Q from measured peak VO2.  
 
METHODS 
Study Population 
We studied 500 voluntary normal subjects who performed a maximal cardiopulmonary exercise test 
(CPET) with Q measurement at peak exercise by IGR. Professional athletes were excluded as well as 
subjects who defined themselves as athletes. Subjects were recruited by public announcement or by 
word of mouth. Study inclusion criteria for normal subjects were: age range between 18 and 80 years, 
absence of present and past significant diseases, normal physical examination, normal 
electrocardiogram, no medical therapy regularly assumed with the exception of oral estroprogestin or 
thyroid replacement therapy, capability to perform a maximal CPET without signs or symptoms of any 
disease. Subjects were asked to refrain from smoking in the 6 hours before the test. All subjects 
underwent at least one teaching session, to understand and practice the IGR methodology. During the 
teaching session, multiple IGR maneuvers with and without gases were done. Subjects who were 
unable to perform the IGR technique were excluded from the present study.  
The study complies with the Declaration of Helsinki, the locally appointed ethics committee approved 
the research protocol (approval number R435/16-CCM451), and informed consent was obtained from 
all subjects. 
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Study Design  
All subjects underwent clinical evaluation associated with collection of health history and recent 
instrumental data.  
All subjects underwent a cycle-ergometer CPET consisting of a personalized ramp protocol based on 
predicted maximum tolerance, with Q measurement by IGR at rest and at peak exercise. To avoid 
possible interferences of the IGR technique with peak VO2 measurements, the latter always preceded Q 
measurements. 
  
Ramp Protocol CPET 
CPET was performed with a progressive work rate increase in a ramp pattern, after at least 3 minutes of 
rest and a brief (at least 2 minutes) unloaded cycling. Expiratory O2, CO2, and ventilation were 
measured breath by breath (Innocor
®
 rebreathing system, Innovision A/S, Odense, Denmark). A 12-lead 
electrocardiogram was recorded (Quark T12x Cosmed, Roma, Italy). Subjects were strongly encouraged 
to perform a maximal test, but the maximum was self-determined when they approached maximal 
exercise, allowing the final 30 seconds for the rebreathing maneuver. The rate of work rate increase 
during the test was decided in order to achieve peak exercise in 8 to 12 minutes during the increasing 
work rate period. Peak VO2 was reported as a mean over the last 20 seconds of exercise. Percentage of 
predicted peak VO2 was calculated according to Wasserman et al. (33). 
 
Q measurement 
The IGR technique uses an oxygen-enriched mixture of an inert soluble gas (0.5% nitrous oxide-N2O) and an 
inert insoluble gas (0.1% sulphur hexafluoride-SF6) from a pre-filled bag (29-31). Subjects breathe into a 
respiratory valve via a mouthpiece and a bacterial filter with a nose clip. At the end of expiration, the valve 
is activated, so that subjects will rebreathe from the pre-filled bag for a period of 10-20 seconds. After this 
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period, subjects are switched back to ambient air, and Q measurement is terminated. Photoacoustic 
analyzers measure gas concentration over a 5-breath interval. SF6 is used to determine lung volume. N2O 
concentration decreases during rebreathing with a rate proportional to pulmonary blood flow (PBF), that is 
the blood flow that perfuses the ventilated alveoli. Q is equal to PBF when the arterial oxygen saturation 
measure (SpO2) is high (> 98% using the pulse oximeter), showing the absence of pulmonary shunt flow. If 
SpO2 < 98%, Q is equal to PBF+shunt flow. The latter can be estimated (29, 32). However, this was not 
needed in the present setting, since only normal subjects were studied.   
Two experts independently read each test and evaluated the linearity of end-expiratory gas pressure 
decay, and the results were averaged.  
 
Statistical Analysis 
Data are expressed as means ± standard deviation; differences between males and females were compared 
by unpaired t-test, while differences between age groups (<40 years versus 41-60 years versus >60 years) 
were compared by ANOVA and Bonferroni post hoc analysis as appropriate. Linear regression analysis was 
performed to assess the best fitting linear relationship between Q and peak VO2, and between age and 
cardiac index (CI), peak VO2 or Q.  
Differences between linear regressions were evaluated by interaction. 
The Bland and Altman method was applied to compare Q measured by IGR with Q estimated by 
Higginbotham formula.  
All tests were two-sided, and a p value below 0.05 was considered as significant. All statistics were 
performed with SPSS for windows or SAS statistical package v.9.2 (SAS Institute Inc., Cary, NC). 
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RESULTS 
Voluntary subjects were recruited until 500 had performed a maximal CPET (peak respiratory quotient = 
1.12± 0.12) and a proper Q measurement at peak exercise by IGR. Consequently, 520 subjects were tested. 
Indeed, 20 subjects voluntarily interrupted the exercise before the IGR maneuver was completed or they 
did not perform a proper IGR measurement at peak exercise. Table 1 shows the anthropometric 
characteristics of the studied population. Resting Q and CI are reported in table 1. Peak VO2 as % of the 
predicted value was 95± 18% in the entire population and 95± 19% and 95±18% in males and females, 
respectively. Peak VO2 and peak Q values were higher in males than in females, both progressively 
decreasing with age (table 2). Similarly, peak exercise Δ(a-v)O2 was higher in males than in females, but it 
was unaffected by age (table 2).  
Peak Q and peak VO2 were strictly related either considering the overall population or considering males 
and females separately (figure 1, panel A and B). The Higginbotham formula applied to the 500 healthy 
subjects demonstrated a relevant dispersion of data compared to Q measured by IGR, and an average 
overestimation of peak Q (0.5±2.4 L/min), which was greater the lower the peak Q (figure 2).  
The correlation between age and peak VO2, both as an absolute value (mL/min) and normalized for body 
weight (mL/min/kg) in the entire population and considering males and females separately, is reported in 
table 3. The correlation between age and peak Q was present but relatively poor, however it improved 
considering the two genders separately. The correlation further improved when CI was used instead of Q, 
particularly in the female gender (table 3). In figure 3, the correlation between age and peak CI is reported 
adding the data from previous reports (12, 15-17, 19, 20, 23, 24, 34-36). 
We also calculated O2 pulse at peak exercise as peak VO2 / peak HR. In figure 4, the correlation between O2 
pulse at peak exercise / peak exercise stroke volume is reported. 
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DISCUSSION 
The present study showed that, in an unselected population of healthy individuals, peak VO2 is strictly 
related to peak Q, and that it varies according to age and gender. This study allowed to provide an equation 
to predict peak Q from peak VO2, showing that, in the general population, peak Q = 4.4 x peak VO2 + 4.3, 
while it is 4.3 x peak VO2 + 4.5 and 4.9 x peak VO2 + 3.6 in males and females, respectively. The above-
reported equations are obtained for the first time from a sizable population of normal subjects (n=500) 
who performed a maximal cycle ergometer exercise – for the entire population and for males and females 
separately. It is of note that several of the previously reported invasive Q measurements (12, 15, 17, 19, 20, 
23, 24, 34, 36) fit with the IGR-obtained peak Q measurement.  
Peak Q had been previously measured invasively in a few studies (12, 15-17, 19, 20, 23, 24, 34-36), which 
had mainly been done in young males. The various studies we were able to evaluate reported a total of 233 
subjects in whom peak Q was measured, using direct Fick, thermo- or dye-dilution techniques. However, 
the subjects studied included a few athletes (n = 44), only 49 females and 66 subjects with an age >50 
years. It should be noted that Julius et al. (19) studied 54 subjects including 19 female subjects, but data are 
reported only combined, so that gender-related differences cannot be separately assessed. Moreover, data 
on subjects over 50 years old were reported separately from those of younger cases only in Julius et al.’s 
report (19). All tests were done on a cycle ergometer except for those by Hossak et al. (24), who used a 
treadmill. For comparison, peak CI in Hossak’s data was reduced by 10% (33). Accordingly, none of the 
above-reported studies, either alone or in combination, provides a reliable population-based measurement 
of peak exercise Q. Therefore, although the invasive measurement of peak Q remains the “gold standard”, 
we performed the present study using the IGR technique, whose reliability has been previously assessed in 
several reports (29-31). Albeit with the limitation of a cross-sectional evaluation, the majority of the data fit 
with our measurements (figure 3), with the exception of Granath et al. (16) and Grimby et al.’s (35) reports, 
which showed a peak CI higher than expected. The explanation for this difference is uncertain , although 
Grimby et al tested middle-age, well trained active athletes (35) and Granath studied a small population 
with an average age of 71 (16). It should be noticed that, also applying the Higginbotham formula, Granath 
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and Grimby’s results were significantly higher than expected. As generally believed, we confirmed that peak 
Q decreases as age increases, and it was lower in females when compared to males of the same age (37), 
regardless of gender-related differences in the mechanisms responsible for Q increase (28).  
A few studies analyzed peak Q as a function of age, gender, and training in normal subjects using non-
invasive estimates of Q (28, 38-40). A direct comparison of these reports’ data with ours is not possible 
because of the limited number of subjects studied, different exercise ergometers, protocols, and Q 
estimation methods. However, also in these studies, older age and female gender were both associated 
with a lower peak Q (38, 39), while different exercise training levels were associated with a different peak 
exercise Q (40). Indeed, Ridout et al (38) found that peak Q was higher in men than in women , and that it 
significantly decreased with age in both sexes . Specifically, they reported a peak Q of 23.6±2.7 vs. 17.4±3.5 
L/min in younger and older males, respectively, and 17.7±1.9 vs. 12.3±.6 L/min in younger and older 
females. Bogaard et al (39) showed a higher peak CI in young (age 20-30y) than in older subjects (age 50-
60), 10.6±2.5 and 7.2±1.3 L/min/m2 (p<0.0005), respectively. Finally, Tomai et al (40) reported a similar 
peak CI in sedentary young male subjects and weight lifters (11.5±1.2 and 10.5±2.7 L/min/m2, p=ns), and a 
significant higher peak CI in swimmers (14.2±2.6 L/min/m2, p<0.01).  
The knowledge of a normal peak exercise Q in the population is extremely important, particularly for 
comparisons with patients who show an exercise performance limitation. In clinical practice, several 
surrogates of peak exercise Q have been proposed, but the most frequently used is O2 Pulse, which is 
calculated as peak VO2 / peak heart rate. Actually, O2 pulse is stroke volme x Δ(a-v)O2. The correlation 
found between O2 pulse and stroke volume was strong (figure 4), suggesting a limited dispersion of Δ(a-
v)O2  at peak exercise. However, the present VO2-derived formula should not be used to estimate exercise Q 
or stroke volume in patients such as HF and COPD patients. Indeed, in HF patients, peak VO2 has a 
recognized pivotal role in the prognosis determination and in the decision making process(41, 42). However, 
a low peak VO2 may be due to several reasons on top of low Q, including muscle impairment, altered blood 
flow distribution to the exercising muscles, and anemia. Similarly, in COPD patients, on top of the above-
reported causes of exercise limitation, hypoxia and ventilation constraint directly affect peak VO2. The 
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Higginbotham formula has been frequently used to estimate peak Q from peak VO2 (5, 25-27). 
Unfortunately, the Higginbotham formula was built on data obtained from 24 young males, a number 
unable to provide a general population evaluation. Moreover, the formula derived from Higginbotham 
measurements was built to calculate the lower limit of normality and not the average normal value. 
Regardless, we measured an average overestimation of peak Q by the Higginbotham formula (27). 
Few study limitations should be acknowledged. Firstly, we measured peak Q only once in each subject. 
Consequently, we did not evaluate the intra-subject variability of peak exercise Q in this series of subjects. 
However, a very limited intra-subject variability has been previously shown with IGR technique in normal 
subjects and in HF patients (29, 43). Secondly, we did not assess peak Q changes with age or physical 
training in the same subject. Thirdly, the role of different feeding habits before exercise on exercise 
performance was not analyzed, nor was the role of cigarette smoking assessed. Furthermore, the utilization 
of the present formula to estimate peak Q from peak VO2 in cases outside the frame of the present study 
should be done with caution, particularly in children and adolescents. Similarly, the application of our 
formula in subjects with an age at the edge of our population’s, such as the elderly, should be done with 
caution. The same caution should be applied in case of well-trained subjects, since athletes were 
specifically excluded from the present study, or in case of particularly deconditioned subjects. A similar 
caution applies to obese subjects. Indeed, although obesity was not a study exclusion criterion, no obese 
subjects responded to our call. A study dedicated to obese subjects is definitely needed. Moreover, we 
studied exercise tests using a cycle-ergometer with peak exercise reached through a ramp exercise protocol 
in ~10 minutes. We do not know whether the present formula can be applied when using a different 
ergometer such as a treadmill or a different exercise protocol. Finally, our formula was built using maximal 
exercise tests, and it should not be applied in case of submaximal tests. 
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CONCLUSIONS 
In conclusion, the present study describes peak exercise Q in a large population of normal subjects of 
different ages and genders, and it provides a formula to estimate Q from measured peak VO2. It is intriguing 
to speculate that, in the near future, simultaneous measurements of both peak Q and VO2 and knowledge 
of both predicted values will become of crucial relevance for the evaluation and treatment of subjects with 
exercise limitation such as HF patients. Indeed, for example in a HF patient, low peak VO2 has a strong 
prognostic power (44), but it may be associated with low Q or preserved Q – in the former case, the failing 
heart becomes the first treatment target, while in the latter case periphery and in general non-heart-
related deficiency should be the main treatment targets.   
 
ACKNOWLEDGEMENTS  
Over time, all Authors listed in the manuscript have substantially contributed to it. In particular: 
Prof. Agostoni: Conception and design of the study, data analysis and interpretation, critical revision and 
manuscript preparation. He is guarantor of the paper, taking responsibility for the integrity of the work as a 
whole, from inception to published article. 
Dr. Vignati: Design of the study, data collection, analysis and interpretation and manuscript preparation. 
Dr. Gentile: Data collection, analysis and interpretation and manuscript preparation. 
Dr. Boiti: Data collection and analysis. 
Dr. Farina: Data collection, analysis and interpretation and manuscript preparation. 
Dr. Salvioni: Data collection, analysis and interpretation and manuscript preparation. 
Dr. Mapelli: Analysis and interpretation and manuscript preparation. 
Dr. Magrì: Data collection, analysis and interpretation. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Dr. Paolillo: Data collection, analysis and interpretation and manuscript preparation. 
Dr. Corrieri: Data collection, analysis and interpretation. 
Prof. Sinagra: Data analysis and interpretation, critical revision and manuscript preparation. 
Dr. Cattadori: Conception and design of the study, data analysis and interpretation, critical revision and 
manuscript preparation. 
Finally, each Author gave their approval to the submission of this manuscript for publication. 
The Authors are grateful to Dr. Michela Palmieri for her contribution in preparing the text. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
REFERENCES 
 
1. Lipkin DP, Poole-Wilson PA. Measurement of cardiac output during exercise by the thermodilution 
and direct Fick techniques in patients with chronic congestive heart failure. The American journal of 
cardiology. 1985;56(4):321-4. Epub 1985/08/01. 
2. Francis GS. Hemodynamic and neurohumoral responses to dynamic exercise: normal subjects 
versus patients with heart disease. Circulation. 1987;76(6 Pt 2):VI11-7. Epub 1987/12/01. 
3. Sullivan MJ, Knight JD, Higginbotham MB, Cobb FR. Relation between central and peripheral 
hemodynamics during exercise in patients with chronic heart failure. Muscle blood flow is reduced with 
maintenance of arterial perfusion pressure. Circulation. 1989;80(4):769-81. Epub 1989/10/01. 
4. Chomsky DB, Lang CC, Rayos GH, Shyr Y, Yeoh TK, Pierson RN, 3rd, et al. Hemodynamic exercise 
testing. A valuable tool in the selection of cardiac transplantation candidates. Circulation. 
1996;94(12):3176-83. Epub 1996/12/15. 
5. Metra M, Faggiano P, D'Aloia A, Nodari S, Gualeni A, Raccagni D, et al. Use of cardiopulmonary 
exercise testing with hemodynamic monitoring in the prognostic assessment of ambulatory patients with 
chronic heart failure. Journal of the American College of Cardiology. 1999;33(4):943-50. Epub 1999/03/26. 
6. Weber KT, Janicki JS. Cardiopulmonary exercise testing for evaluation of chronic cardiac failure. The 
American journal of cardiology. 1985;55(2):22A-31A. Epub 1985/01/11. 
7. Schlosshan D, Barker D, Pepper C, Williams G, Morley C, Tan LB. CRT improves the exercise capacity 
and functional reserve of the failing heart through enhancing the cardiac flow- and pressure-generating 
capacity. European journal of heart failure. 2006;8(5):515-21. Epub 2005/12/27. 
8. Balady GJ, Arena R, Sietsema K, Myers J, Coke L, Fletcher GF, et al. Clinician's Guide to 
cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association. 
Circulation. 2010;122(2):191-225. Epub 2010/06/30. 
9. Welsman J, Bywater K, Farr C, Welford D, Armstrong N. Reliability of peak VO(2) and maximal 
cardiac output assessed using thoracic bioimpedance in children. European journal of applied physiology. 
2005;94(3):228-34. Epub 2005/04/14. 
10. Moore R, Sansores R, Guimond V, Abboud R. Evaluation of cardiac output by thoracic electrical 
bioimpedance during exercise in normal subjects. Chest. 1992;102(2):448-55. Epub 1992/08/01. 
11. Nugent AM, McParland J, McEneaney DJ, Steele I, Campbell NP, Stanford CF, et al. Non-invasive 
measurement of cardiac output by a carbon dioxide rebreathing method at rest and during exercise. 
European heart journal. 1994;15(3):361-8. Epub 1994/03/01. 
12. Stringer WW, Hansen JE, Wasserman K. Cardiac output estimated noninvasively from oxygen 
uptake during exercise. J Appl Physiol (1985). 1997;82(3):908-12. Epub 1997/03/01. 
13. Cotter G, Moshkovitz Y, Kaluski E, Milo O, Nobikov Y, Schneeweiss A, et al. The role of cardiac 
power and systemic vascular resistance in the pathophysiology and diagnosis of patients with acute 
congestive heart failure. European journal of heart failure. 2003;5(4):443-51. Epub 2003/08/19. 
14. Cohen-Solal A, Tabet JY, Logeart D, Bourgoin P, Tokmakova M, Dahan M. A non-invasively 
determined surrogate of cardiac power ('circulatory power') at peak exercise is a powerful prognostic factor 
in chronic heart failure. European heart journal. 2002;23(10):806-14. Epub 2002/05/16. 
15. Higginbotham MB, Morris KG, Williams RS, McHale PA, Coleman RE, Cobb FR. Regulation of stroke 
volume during submaximal and maximal upright exercise in normal man. Circulation research. 
1986;58(2):281-91. Epub 1986/02/01. 
16. Granath A, Jonsson B, Strandell T. Circulation in Healthy Old Men, Studied by Right Heart 
Catheterization at Rest and during Exercise in Supine and Sitting Position. Acta medica Scandinavica. 
1964;176:425-46. Epub 1964/10/01. 
17. Bevegard S, Holmgren A, Jonsson B. Circulatory studies in well trained athletes at rest and during 
heavy exercise. With special reference to stroke volume and the influence of body position. Acta 
physiologica Scandinavica. 1963;57:26-50. Epub 1963/01/01. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
18. Stringer WW, Whipp BJ, Wasserman K, Porszasz J, Christenson P, French WJ. Non-linear cardiac 
output dynamics during ramp-incremental cycle ergometry. European journal of applied physiology. 
2005;93(5-6):634-9. Epub 2004/12/04. 
19. Julius S, Amery A, Whitlock LS, Conway J. Influence of age on the hemodynamic response to 
exercise. Circulation. 1967;36(2):222-30. Epub 1967/08/01. 
20. Sullivan MJ, Cobb FR, Higginbotham MB. Stroke volume increases by similar mechanisms during 
upright exercise in normal men and women. The American journal of cardiology. 1991;67(16):1405-12. 
Epub 1991/06/15. 
21. Rodeheffer RJ, Gerstenblith G, Becker LC, Fleg JL, Weisfeldt ML, Lakatta EG. Exercise cardiac output 
is maintained with advancing age in healthy human subjects: cardiac dilatation and increased stroke 
volume compensate for a diminished heart rate. Circulation. 1984;69(2):203-13. Epub 1984/02/01. 
22. Vella CA, Robergs RA. A review of the stroke volume response to upright exercise in healthy 
subjects. British journal of sports medicine. 2005;39(4):190-5. Epub 2005/03/29. 
23. Thadani U, Parker JO. Hemodynamics at rest and during supine and sitting bicycle exercise in 
normal subjects. The American journal of cardiology. 1978;41(1):52-9. Epub 1978/01/01. 
24. Hossack KF, Bruce RA. Maximal cardiac function in sedentary normal men and women: comparison 
of age-related changes. Journal of applied physiology: respiratory, environmental and exercise physiology. 
1982;53(4):799-804. Epub 1982/10/01. 
25. Gordon A, Tyni-Lenne R, Jansson E, Jensen-Urstad M, Kaijser L. Beneficial effects of exercise training 
in heart failure patients with low cardiac output response to exercise - a comparison of two training 
models. Journal of internal medicine. 1999;246(2):175-82. Epub 1999/08/14. 
26. Mancini D, Katz S, Donchez L, Aaronson K. Coupling of hemodynamic measurements with oxygen 
consumption during exercise does not improve risk stratification in patients with heart failure. Circulation. 
1996;94(10):2492-6. Epub 1996/11/15. 
27. Wilson JR, Groves J, Rayos G. Circulatory status and response to cardiac rehabilitation in patients 
with heart failure. Circulation. 1996;94(7):1567-72. Epub 1996/10/01. 
28. Higginbotham MB, Morris KG, Coleman RE, Cobb FR. Sex-related differences in the normal cardiac 
response to upright exercise. Circulation. 1984;70(3):357-66. Epub 1984/09/01. 
29. Agostoni P, Cattadori G, Apostolo A, Contini M, Palermo P, Marenzi G, et al. Noninvasive 
measurement of cardiac output during exercise by inert gas rebreathing technique: a new tool for heart 
failure evaluation. Journal of the American College of Cardiology. 2005;46(9):1779-81. Epub 2005/11/01. 
30. Goda A, Lang CC, Williams P, Jones M, Farr MJ, Mancini DM. Usefulness of non-invasive 
measurement of cardiac output during sub-maximal exercise to predict outcome in patients with chronic 
heart failure. The American journal of cardiology. 2009;104(11):1556-60. Epub 2009/11/26. 
31. Elkayam U, Wilson AF, Morrison J, Meltzer P, Davis J, Klosterman P, et al. Non-invasive 
measurement of cardiac output by a single breath constant expiratory technique. Thorax. 1984;39(2):107-
13. Epub 1984/02/01. 
32. Farina S, Teruzzi G, Cattadori G, Ferrari C, De Martini S, Bussotti M, et al. Noninvasive cardiac 
output measurement by inert gas rebreathing in suspected pulmonary hypertension. The American journal 
of cardiology. 2014;113(3):546-51. Epub 2013/12/10. 
33. Wasserman K, Hansen JE, Sue DY, Stringer WW, Whipp BJ. Clinical Exercise Testing.  Principles of 
Exercise Testing and Interpretation Including Pathophysiology and Clinical Applications: Lippincott Williams 
& Wilkins; 2005. p. 138-9. 
34. Astrand PO, Ekblom B, Messin R, Saltin B, Stenberg J, Wallstrom B. Effect of training on circulation 
during exercise.  Intern Congr Physiol Sci, 23rd; Tokyo1965. 
35. Grimby G, Nilsson NJ, Saltin B. Cardiac output during submaximal and maximal exercise in active 
middle-aged athletes. Journal of applied physiology. 1966;21(4):1150-6. Epub 1966/07/01. 
36. Astrand PO, Cuddy TE, Saltin B, Stenberg J. Cardiac Output during Submaximal and Maximal Work. 
Journal of applied physiology. 1964;19:268-74. Epub 1964/03/01. 
37. Astrand PO. Human physical fitness with special reference to sex and age. Physiological reviews. 
1956;36(3):307-35. Epub 1956/07/01. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
38. Ridout SJ, Parker BA, Smithmyer SL, Gonzales JU, Beck KC, Proctor DN. Age and sex influence the 
balance between maximal cardiac output and peripheral vascular reserve. J Appl Physiol (1985). 
2010;108(3):483-9. Epub 2009/12/05. 
39. Bogaard HJ, Woltjer HH, Dekker BM, van Keimpema AR, Postmus PE, de Vries PM. Haemodynamic 
response to exercise in healthy young and elderly subjects. European journal of applied physiology and 
occupational physiology. 1997;75(5):435-42. Epub 1997/01/01. 
40. Tomai F, Ciavolella M, Gaspardone A, De Fazio A, Basso EG, Giannitti C, et al. Peak exercise left 
ventricular performance in normal subjects and in athletes assessed by first-pass radionuclide angiography. 
The American journal of cardiology. 1992;70(4):531-5. Epub 1992/08/15. 
41. Guazzi M, Adams V, Conraads V, Halle M, Mezzani A, Vanhees L, et al. EACPR/AHA Scientific 
Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific 
patient populations. Circulation. 2012;126(18):2261-74. Epub 2012/09/07. 
42. Agostoni P, Corra U, Cattadori G, Veglia F, La Gioia R, Scardovi AB, et al. Metabolic exercise test 
data combined with cardiac and kidney indexes, the MECKI score: a multiparametric approach to heart 
failure prognosis. International journal of cardiology. 2013;167(6):2710-8. Epub 2012/07/17. 
43. Nielsen OW, Hansen S, Gronlund J. Precision and accuracy of a noninvasive inert gas washin 
method for determination of cardiac output in men. J Appl Physiol (1985). 1994;76(4):1560-5. Epub 
1994/04/01. 
44. Lang CC, Agostoni P, Mancini DM. Prognostic significance and measurement of exercise-derived 
hemodynamic variables in patients with heart failure. Journal of cardiac failure. 2007;13(8):672-9. Epub 
2007/10/10. 
45. Thadani U, West RO, Mathew TM, Parker JO. Hemodynamics at rest and during supine and sitting 
bicycle exercise in patients with coronary artery disease. The American journal of cardiology. 
1977;39(6):776-83. Epub 1977/05/26. 
 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
FIGURE LEGEND 
Figure 1: Panel A: Relation between VO2 (L/min) and cardiac output (L/min) at peak exercise. Best fitting 
linear regression between peak VO2 and peak Q in the total population and separately in males (blue 
circles) and in females (pink circles). 
Panel B: Relation between peak VO2 (L/min/m
2
) and cardiac index (L/min/m
2
) at peak exercise. Symbols as 
in panel A. 
Figure 2: Bland-Altman plot for cardiac output (Q). 
Plot of the differences between Higginbotham formula and IGR method to measure Q in healthy subjects. 
The dotted blue line identifies the linear relationship between differences and average values, the red line 
identifies the mean of the difference between the two techniques, the black lines express the mean ± 1.96 
standard deviation. 
Figure 3: Relation between age and cardiac index at peak exercise. 
Linear regression between age and cardiac index in the studied population (n= 500 subjects). The circles 
represent data obtained in previous studies (12, 15-17, 19, 20, 24, 34-36, 45). 
Figure 4: Relation between stroke volume (SV) and O2 pulse at peak exercise in the total population and 
separately in males (blue circles) and in females (pink circles). 
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Table 1: Anthropometric characteristics of the studied population (n=500). 
 
 
 
 
 
Data are mean ± standard deviation. Q= Cardiac output; CI= Cardiac Index. Age distribution was: a) age 18-40 years 181/88/93 in the entire 
population and in males and females, respectively; age >40-60 aa 242/134/108; age >60-80 77/38/39. 
 
 
 
 
 All (n=500) Males (n= 260) Females (n=240) p 
Age (years) 
 
45.0 
range 
± 13.5 
18-77 
45.2 
range 
± 13.1 
18-77 
44.7 
range 
± 13.8 
21-75 
ns 
Weight (Kg) 68.6 ± 13.3 77.2 ± 10.3 59.4 ± 9.5 <0.001 
Height (cm) 171 ± 9 177 ± 7 164 ± 6 <0.001 
Hb (g/dl) 14.4 ± 1.0  14.9 ± 0.5 13.8 ± 1.1 <0.001 
Rest Q (L/min) 5.4 ± 1.5 5.9 ± 1.5 4.8 ± 1.3 <0.001 
Rest CI (L/min/m
2
) 3.0 ± 0.8 3.1 ± 0.8 2.9 ± 0.8 <0.05 
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Table 2: Data at peak exercise in the total population and by gender. 
 
Data are mean ± standard deviation. M= Males; F= Females; VO2= Oxygen uptake; Q= Cardiac output; Δ(a-v)= Arteriovenous O2 differences, HR= 
Heart rate; SV= Stroke volume; CI= Cardiac Index 
 
Bonferroni post hoc (entire population by age group):*: p<0.01 vs Age 41-40; y: p<0.01 vs Age>60; z:p<0.05 vs Age >60 
  Peak VO2 
(mL/min) 
Peak Q 
(L/min) 
Peak Δ(a-v) 
(mL/100mL) 
Peak HR 
(bpm) 
Peak SV 
(mL) 
Peak CI 
(L/min/m
2
) 
Total 
Population 
All (n=500) 2025±668 13.2±3.5 15.2±2.7 157±19 84.5±21.6 7.33±1.59 
M (n=260) 2494±560 15.3±3.4 16.5±2.7 158±20 96.7±20.3 7.87±1.69 
F (n=240) 1518±309 11±2.1 13.8±2 156±18 71±13.7 6.75±1.24 
 p M vs. F <0.001 <0.001 <0.001 NS <0.001 <0.001 
Age ≤40 All(n=181) 2175±688# 14.4±3.4*y 15±2.5 168±14*y 86.2±19.9z 8.15±1.46*y 
M (n=88) 2735±532 16.9±2.9 16.3±2.5 170±16 100.1±16.9 8.82±1.57 
F (n=93) 1646±277 12.1±1.8 13.7±1.8 167±13 73±12.2 7.52±1.02 
 p M vs. F <0.001 <0.001 <0.001 NS <0.001 <0.001 
Age 41-60 All(n=242) 2042±655# 13.1±3.4y 15.5±2.8 155±17y 85.1±22.6 7.13±1.41y 
M (n=134) 2485±515 15.1±3.1 16.7±2.8 156±18 96.7±21.2 7.64±1.45 
F(n=108) 1492±292 10.7±1.9 14±2 153±17 70.5±14.4 6.49±1.05 
 p M vs. F <0.001 <0.001 <0.001 NS <0.001 <0.001 
Age>60 All (n=77) 1627±483 10.8±2.7 15.1±3 139±20 78.9±21.5 6.04±1.37 
M (n=38) 1969±392 12.2±2.9 16.5±2.9 139±22 89.1±22.5 6.49±1.51 
F (n=39) 1286±283 9.5±1.7 13.7±2.4 140±17 68.8±14.9 5.59±1.06 
 p M vs. F <0.001 <0.001 <0.001 NS <0.001 <0.01 
ANOVA 
(entire population 
by age group) 
p <0.001 <0.001 ns <0.001 0.043 <0.001 
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Table 3: Correlations between Age and VO2, CO and CI at peak exercise 
 
  R
2
 p equation 
Age vs. peak VO2 
All 0.082 <0.001 Age=-5.78×peakVO2+56.69 
M 0.225 <0.001 Age=-0.01×peakVO2+73.04 
F 0.198 <0.001 Age=-0.02×peakVO2+74.85 
Age vs. peak Q 
All 0.144 <0.001 Age=-0.10×peakQ+17.72 
M 0.261 <0.001 Age=-0.13×peakQ+21.19 
F 0.257 <0.001 Age=-0.08×peakQ+14.10 
Age vs. peak CI 
All 0.254 <0.001 Age=-4.27×peakCI+76.26 
M 0.263 <0.001 Age=-3.99×peakCI+76.75 
F 0.379 <0.001 Age=-6.86×peakCI+90.93 
Age vs. peak dAV 
All 0.002 ns Age=0.24×peak Δ(a-v)O2+41.39 
M 0.003 ns Age=-0.25×peak Δ(a-v)O2+41.14 
F 0.001 ns Age=0.22×peak Δ(a-v)O2+41.63 
M= Males; F= Females; VO2= Oxygen uptake; Q= Cardiac output; CI= Cardiac Index; Δ(a-v)O2= arteriovenous difference 
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ABBREVIATIONS LIST 
- Cardiac output (CO) 
- Heart failure (HF) 
- Oxygen uptake (VO2) 
- Inert gas rebreathing (IGR) 
- Cardiopulmonary exercise test (CPET) 
- Pulmonary blood flow (PBF) 
- Arterial oxygen saturation (SpO2) 
- Cardiac Index (CI) 
